Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Merck
Covington
Medtronic
Teva
Argus Health
Fuji
Boehringer Ingelheim
Colorcon
Julphar

Generated: October 19, 2017

DrugPatentWatch Database Preview

Flucytosine - Generic Drug Details

« Back to Dashboard

What are the generic sources for flucytosine and what is the scope of flucytosine patent protection?

Flucytosine
is the generic ingredient in two branded drugs marketed by Valeant, Novel Labs Inc, and Sigmapharm Labs Llc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for flucytosine. Six suppliers are listed for this compound.

Summary for Generic Name: flucytosine

US Patents:0
Tradenames:2
Applicants:3
NDAs:3
Drug Master File Entries: see list6
Suppliers / Packagers: see list6
Bulk Api Vendors: see list124
Clinical Trials: see list25
Patent Applications: see list7,224
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:flucytosine at DailyMed

Pharmacology for Ingredient: flucytosine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs Inc
FLUCYTOSINE
flucytosine
CAPSULE;ORAL204652-001Jul 7, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Sigmapharm Labs Llc
FLUCYTOSINE
flucytosine
CAPSULE;ORAL201566-001Jun 28, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Novel Labs Inc
FLUCYTOSINE
flucytosine
CAPSULE;ORAL204652-002Jul 7, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Valeant
ANCOBON
flucytosine
CAPSULE;ORAL017001-002Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Sigmapharm Labs Llc
FLUCYTOSINE
flucytosine
CAPSULE;ORAL201566-002Jun 28, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Valeant
ANCOBON
flucytosine
CAPSULE;ORAL017001-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Medtronic
Harvard Business School
Cipla
McKesson
AstraZeneca
Mallinckrodt
Queensland Health
Merck
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot